(Q42733531)

6 November 2017

title

Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris (English)

1 reference

6 November 2017

1 reference

Hamidreza Pazoki-Toroudi

1

1 reference

6 November 2017

Mohamad Ali Nilforoushzadeh

2

1 reference

6 November 2017

Marjan Ajami

3

1 reference

6 November 2017

Fariba Jaffary

4

1 reference

6 November 2017

Nahid Aboutaleb

5

1 reference

6 November 2017

Mansour Nassiri-Kashani

6

1 reference

6 November 2017

Alireza Firooz

7

1 reference

6 November 2017

language of work or name

English

0 references

publication date

25 May 2011

1 reference

Cutaneous and Ocular Toxicology

6 November 2017

published in

1 reference

6 November 2017

volume

30

1 reference

6 November 2017

issue

4

1 reference

6 November 2017

page(s)

286-291

1 reference

Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial

6 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Inflammatory events are involved in acne lesion initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Inflammation in acne vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Azelaic acid (15% gel) in the treatment of acne rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Efficacy of topical azelaic acid gel in the treatment of mild-moderate acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Azelaic acid (20%) cream in the treatment of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Systemic antibiotic therapy of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Updates on the pathophysiology and management of acne rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Management of acne vulgaris: focus on clindamycin and zinc

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Clindamycin phosphate 1% gel in acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Topical clindamycin in the management of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Treatment of acne with topical antibiotics: lessons from clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Clindamycin/benzoyl peroxide gel (BenzaClin): a review of its use in the management of acne

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Effects of azelaic acid on proliferation and ultrastructure of mouse keratinocytes in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Acne vulgaris. The role of hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Combination azelaic acid therapy for acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Multimodal treatment of acne, acne scars and pigmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Clindamycin and benzoyl peroxide combined was more effective than either agent alone or placebo for acne vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Clindamycin lotion alone versus combination lotion of clindamycin phosphate plus tretinoin versus combination lotion of clindamycin phosphate plus salicylic acid in the topical treatment of mild to moderate acne vulgaris: a randomized control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

A novel gel formulation of 0.25% tretinoin and 1.2% clindamycin phosphate: efficacy in acne vulgaris patients aged 12 to 18 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15569527.2011.581257

10.3109/15569527.2011.581257

21 January 2018

Identifiers

DOI

1 reference

6 November 2017

1 reference